Operating income, growth figures, profitability and how our products have behaved.
Thu, 05/11/2020 - 00:00
0 minOperating income, growth figures, profitability and how our products have behaved.
Related
ROVI reports operating revenue growth of 24% and EBITDA growth of 25%
• Operating revenue increased by 24% to 575.5 million euros driven...
3 min
04/11/2022
On his visit to the plant, which is ready to start production as soon as the authorisation from the Spanish Agency of Medicines and...
4 min
24/10/2022
Glicopepton Biotech founded to produce compounds of high technological value
· ROVI, Càrniques Celrà and Grupo Costa announce...
3 min
04/10/2022
6S3A6968(3).jpg